001     127444
005     20240228140928.0
024 7 _ |a 10.1016/j.celrep.2015.08.024
|2 doi
024 7 _ |a pmid:26344773
|2 pmid
024 7 _ |a altmetric:4486336
|2 altmetric
037 _ _ |a DKFZ-2017-03467
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Savant, Soniya
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a The Orphan Receptor Tie1 Controls Angiogenesis and Vascular Remodeling by Differentially Regulating Tie2 in Tip and Stalk Cells.
260 _ _ |a Maryland Heights, MO
|c 2015
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1508311293_2459
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Tie1 is a mechanistically poorly characterized endothelial cell (EC)-specific orphan receptor. Yet, Tie1 deletion is embryonic lethal and Tie1 has been implicated in critical vascular pathologies, including atherosclerosis and tumor angiogenesis. Here, we show that Tie1 does not function independently but exerts context-dependent effects on the related receptor Tie2. Tie1 was identified as an EC activation marker that is expressed during angiogenesis by a subset of angiogenic tip and remodeling stalk cells and downregulated in the adult quiescent vasculature. Functionally, Tie1 expression by angiogenic EC contributes to shaping the tip cell phenotype by negatively regulating Tie2 surface presentation. In contrast, Tie1 acts in remodeling stalk cells cooperatively to sustain Tie2 signaling. Collectively, our data support an interactive model of Tie1 and Tie2 function, in which dynamically regulated Tie1 versus Tie2 expression determines the net positive or negative effect of Tie1 on Tie2 signaling.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Receptor, TIE-1
|0 EC 2.7.10.1
|2 NLM Chemicals
650 _ 7 |a Receptor, TIE-2
|0 EC 2.7.10.1
|2 NLM Chemicals
700 1 _ |a La Porta, Silvia
|0 P:(DE-He78)b8f19c256fc9d795781f1e0c6e7c5c6d
|b 1
|u dkfz
700 1 _ |a Budnik, Annika
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Busch, Katrin
|0 P:(DE-He78)6695811f3270b3dbe3d06842e2ca55cd
|b 3
|u dkfz
700 1 _ |a Hu, Junhao
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Tisch, Nathalie
|b 5
700 1 _ |a Korn, Claudia
|0 P:(DE-He78)9f5445b47d46f5f026560c307119a7da
|b 6
|u dkfz
700 1 _ |a Valls, Aida Freire
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Benest, Andrew V
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Terhardt, Dorothee
|0 P:(DE-He78)991812504757f41fde96045ecacfe0f5
|b 9
|u dkfz
700 1 _ |a Qu, Xianghu
|b 10
700 1 _ |a Adams, Ralf H
|b 11
700 1 _ |a Baldwin, H Scott
|b 12
700 1 _ |a Ruiz de Almodóvar, Carmen
|b 13
700 1 _ |a Rodewald, Hans-Reimer
|0 P:(DE-He78)86fa3316b7be0d661065d02b3baec3d6
|b 14
|u dkfz
700 1 _ |a Augustin, Hellmut
|0 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b
|b 15
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.celrep.2015.08.024
|g Vol. 12, no. 11, p. 1761 - 1773
|0 PERI:(DE-600)2649101-1
|n 11
|p 1761 - 1773
|t Cell reports
|v 12
|y 2015
|x 2211-1247
909 C O |o oai:inrepo02.dkfz.de:127444
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)b8f19c256fc9d795781f1e0c6e7c5c6d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)6695811f3270b3dbe3d06842e2ca55cd
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)9f5445b47d46f5f026560c307119a7da
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)991812504757f41fde96045ecacfe0f5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)86fa3316b7be0d661065d02b3baec3d6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|2 G:(DE-HGF)POF3-300
|v Signalling pathways, cell and tumor biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL REP : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)
|0 LIC:(DE-HGF)CCBYNCNDNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CELL REP : 2015
920 1 _ |0 I:(DE-He78)A190-20160331
|k A190
|l Vaskuläre Onkologie und Metastasierung
|x 0
920 1 _ |0 I:(DE-He78)D110-20160331
|k D110
|l Zelluläre Immunologie
|x 1
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A190-20160331
980 _ _ |a I:(DE-He78)D110-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21